Product
Verelan PM
Aliases
Verelan® PM Extended-Release Capsules 300 mg, Verelan® PM Extended-Release Capsules, 300 mg
Name
Verelan
INN Name
verapamil hydrochloride
FDA Approved
Yes
4 clinical trials
1 organization
1 indication
1 document
Indication
HealthyClinical trial
Single-Dose Fasting Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg; Mylan) to Verelan® PM Extended-Release Capsules (300 mg; Schwarz) in Healthy Volunteers Dosed in the EveningStatus: Completed, Estimated PCD: 2006-01-01
Clinical trial
Single-Dose Fed Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg; Mylan) and Verelan® PM Extended-Release Capsules (300 mg; Schwarz) in Healthy VolunteersStatus: Completed, Estimated PCD: 2006-01-01
Clinical trial
Single-Dose Fasting Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg;Mylan) and Verelan® PM Extended-Release Capsules (300 mg; Schwarz) Sprinkled on Applesauce in Healthy VolunteersStatus: Completed, Estimated PCD: 2006-01-01
Clinical trial
Single-Dose Fasting Bioequivalence Study of Verapamil HCl Extended-Release Capsules (300 mg; Mylan) to Verelan® PM Extended-Release Capsules (300 mg; Schwarz) in Healthy Volunteers Dosed in the EveningStatus: Completed, Estimated PCD: 2006-03-01
Document
DailyMed Label: VERELAN PMOrganization
Physicians Total Care, Inc.